论文部分内容阅读
AIM:To describe our clinical experience in treating circumscribed choroidal haemangioma(CCH)in a tertiary referral centre over a fifteen year period prior to photodynamic therapy. METHODS:The departmental database and photographic records of a tertiary referral center were used to identify patients who were treated for CCH between 1992 and 2007. Their case records were reviewed. RESULTS:Visual acuity improved(>2 Snellen lines)in eleven patients(69%)remained stable in one patient(6%) and deteriorated in four patients(25%).Six of the seven treated with brachytherapy and three of the four treated with transpupillary thermotherapy achieved better visual acuity after treatment.86%of patients treated within six months of onset of symptoms and 50%of patients treated after six months of onset of symptoms noted an improvement in visual acuity.Only one patient in our series had a final VA of 6/60 or worse.Mean follow-up was thirty-five months. CONCLUSION:Visual outcome is better when treatment is performed within 6 months of symptoms.The majority of patients achieved an improvement in visual acuity without any adverse effect following treatment.
AIM: To describe our clinical experience in treating circumscribed chromatin haemangioma (CCH) in a tertiary referral center over a fifteen year period prior to photodynamic therapy. METHODS: The departmental database and photographic records of a tertiary referral center were used to identify patients who were treated for CCH between 1992 and 2007. Their case records were reviewed. RESULTS: Visual acuity improved (> 2 Snellen lines) in eleven patients (69%) remained stable in one patient (6%) and deteriorated in four patients . Six of the seven treated with brachytherapy and three of the four treated with transpupillary thermotherapy achieved better visual acuity after treatment.86% of patients treated within six months of onset of symptoms and 50% of patients treated after six months of onset of symptoms not noted an improvement in visual acuity. One of the patients in our series had a final VA of 6/60 or worse.Mean follow-up was thirty-five months. CONCLUSION: Visual outcome is better when treatment i s performed within 6 months of symptoms.The majority of patients achieved an improvement in visual acuity without any adverse effect following treatment.